Share Price and Basic Stock Data
Last Updated: October 22, 2025, 9:09 am
| PEG Ratio | 0.14 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Morgan Ventures Ltd operates in the Non-Banking Financial Company (NBFC) sector, with its stock currently priced at ₹72.00 and a market capitalization of ₹71.2 Cr. The company has shown a volatile revenue trend over the last several quarters. For instance, sales reported in June 2022 were ₹9.00 Cr, which declined to ₹3.93 Cr in September 2023, before rebounding to ₹10.91 Cr in March 2024. The trailing twelve months (TTM) sales stood at ₹45 Cr, reflecting a significant recovery from prior lows. However, the operating profit margin (OPM) fluctuated notably, with a high of 99.44% in June 2022, but it fell to 61.84% by June 2025. This indicates a potential challenge in maintaining profitability amidst operational pressures. The cash conversion cycle (CCC) remained impressively low at 0 days, suggesting efficient management of working capital, which is crucial for an NBFC’s operational success.
Profitability and Efficiency Metrics
The profitability ratios for Morgan Ventures Ltd exhibit significant strengths, particularly its return on equity (ROE) of 32.0% and a return on capital employed (ROCE) of 18.3%, both of which are commendably high compared to typical industry standards. The net profit for the most recent quarter, June 2025, was reported at ₹1.05 Cr, with earnings per share (EPS) at ₹1.06. The interest coverage ratio (ICR) stood at an astonishing 9984.77x, indicating the company’s robust ability to cover interest obligations. However, the company experienced net profit declines in several quarters, with notable losses in December 2022 and March 2023. The operating profit margin (OPM) also saw significant variability, which raises concerns about the sustainability of profit levels amid fluctuating sales. Overall, while Morgan Ventures Ltd showcases strong profitability metrics, the volatility in net profit and OPM suggests a need for improved operational consistency.
Balance Sheet Strength and Financial Ratios
Morgan Ventures Ltd’s balance sheet reflects a cautious yet strategic approach to leverage and capital management. As of June 2025, the company’s borrowings amounted to ₹171 Cr, against reserves of ₹79 Cr, resulting in a debt-to-equity ratio that indicates a reliance on debt financing. The total liabilities stood at ₹278 Cr, with total assets of the same amount, suggesting a balanced approach. Furthermore, the price-to-book value (P/BV) ratio is exceptionally low at 0.18x, indicating that the stock may be undervalued relative to its net assets. The liquidity ratios, including a current ratio of 2.49x and a quick ratio of 0.62x, suggest that the company maintains adequate short-term liquidity, although the quick ratio indicates some reliance on inventory. Overall, while the financial ratios indicate a sound balance sheet, the significant level of borrowings poses a risk if the company encounters cash flow issues.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Morgan Ventures Ltd reveals a strong promoter backing, with promoters holding 74.80% of the shares as of June 2025. This significant stake indicates a robust commitment to the company by its founders, which can enhance investor confidence. The public holds 25.18% of the shares, with a steady increase in the number of shareholders that rose to 6,085 by June 2025, reflecting growing interest among retail investors. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) suggests a lack of institutional confidence, which could be a concern for long-term stability and support. The consistent shareholding by promoters and increasing public participation may provide a cushion, but the lack of institutional backing could limit the stock’s potential for significant upward movement in the market.
Outlook, Risks, and Final Insight
If margins sustain and the company continues to improve its operational efficiency, Morgan Ventures Ltd could leverage its strong profitability metrics to attract institutional investors, thereby enhancing market confidence. However, the risks associated with high levels of debt and historical revenue volatility cannot be overlooked. The company must focus on stabilizing its sales and managing expenses effectively to maintain profitability. Any significant downturn in operational performance could jeopardize its impressive interest coverage ratio and ultimately impact its ability to service debt. Additionally, the lack of institutional interest poses a risk to liquidity and market perception. Therefore, while Morgan Ventures Ltd has the potential to thrive, it must navigate these challenges carefully to ensure sustainable growth and investor confidence in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Morgan Ventures Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 15.9 Cr. | 1.59 | 1.91/0.85 | 106 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 |
| Money Masters Leasing & Finance Ltd | 12.2 Cr. | 1.21 | 14.3/1.06 | 19.0 | 1.31 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 548 Cr. | 167 | 285/130 | 79.8 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 17.8 Cr. | 19.4 | 39.8/17.5 | 13.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 45.7 Cr. | 102 | 181/90.0 | 24.5 | 238 | 0.98 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,944.91 Cr | 491.08 | 104.30 | 494.63 | 0.21% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.00 | 7.04 | -3.69 | -0.36 | 3.59 | 3.93 | 4.56 | 10.91 | 5.89 | 12.48 | 14.46 | 12.42 | 5.53 |
| Expenses | 0.05 | 0.07 | 0.07 | 2.12 | 0.08 | 0.10 | 0.06 | 0.17 | 0.83 | 0.12 | 0.06 | 0.33 | 2.11 |
| Operating Profit | 8.95 | 6.97 | -3.76 | -2.48 | 3.51 | 3.83 | 4.50 | 10.74 | 5.06 | 12.36 | 14.40 | 12.09 | 3.42 |
| OPM % | 99.44% | 99.01% | 97.77% | 97.46% | 98.68% | 98.44% | 85.91% | 99.04% | 99.59% | 97.34% | 61.84% | ||
| Other Income | 0.00 | 0.00 | 0.77 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 1.39 | 0.07 | 0.00 | 0.00 | 0.00 |
| Interest | 0.62 | 0.35 | 0.54 | 0.85 | 1.46 | 1.61 | 2.04 | 3.62 | 2.36 | 3.72 | 1.99 | 4.22 | 2.76 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 8.33 | 6.62 | -3.53 | -3.33 | 2.06 | 2.23 | 2.46 | 7.12 | 4.09 | 8.71 | 12.41 | 7.87 | 0.66 |
| Tax % | 27.13% | 11.33% | -25.21% | -18.32% | 35.92% | 11.66% | 25.20% | 32.44% | -22.49% | 36.97% | 25.14% | 14.87% | -57.58% |
| Net Profit | 6.07 | 5.87 | -2.64 | -2.72 | 1.32 | 1.98 | 1.84 | 4.81 | 5.01 | 5.50 | 9.28 | 6.70 | 1.05 |
| EPS in Rs | 6.13 | 5.93 | -2.67 | -2.75 | 1.33 | 2.00 | 1.86 | 4.86 | 5.06 | 5.56 | 9.37 | 6.77 | 1.06 |
Last Updated: August 19, 2025, 1:00 pm
Below is a detailed analysis of the quarterly data for Morgan Ventures Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 5.53 Cr.. The value appears to be declining and may need further review. It has decreased from 12.42 Cr. (Mar 2025) to 5.53 Cr., marking a decrease of 6.89 Cr..
- For Expenses, as of Jun 2025, the value is 2.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.33 Cr. (Mar 2025) to 2.11 Cr., marking an increase of 1.78 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.42 Cr.. The value appears to be declining and may need further review. It has decreased from 12.09 Cr. (Mar 2025) to 3.42 Cr., marking a decrease of 8.67 Cr..
- For OPM %, as of Jun 2025, the value is 61.84%. The value appears to be declining and may need further review. It has decreased from 97.34% (Mar 2025) to 61.84%, marking a decrease of 35.50%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 2.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.22 Cr. (Mar 2025) to 2.76 Cr., marking a decrease of 1.46 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 7.87 Cr. (Mar 2025) to 0.66 Cr., marking a decrease of 7.21 Cr..
- For Tax %, as of Jun 2025, the value is -57.58%. The value appears to be improving (decreasing) as expected. It has decreased from 14.87% (Mar 2025) to -57.58%, marking a decrease of 72.45%.
- For Net Profit, as of Jun 2025, the value is 1.05 Cr.. The value appears to be declining and may need further review. It has decreased from 6.70 Cr. (Mar 2025) to 1.05 Cr., marking a decrease of 5.65 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.06. The value appears to be declining and may need further review. It has decreased from 6.77 (Mar 2025) to 1.06, marking a decrease of 5.71.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:02 am
| Metric | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 1 | -0 | -0 | 0 | -3 | 1 | 6 | 17 | 12 | 23 | 45 | 45 |
| Expenses | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 | 3 |
| Operating Profit | 3 | -1 | -0 | -0 | -0 | -3 | 1 | 6 | 15 | 10 | 23 | 44 | 42 |
| OPM % | 63% | -196% | -2,900% | 77% | 95% | 91% | 81% | 98% | 97% | 94% | |||
| Other Income | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 1 | -0 | 1 | 0 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 3 | 4 | 2 | 9 | 12 | 13 |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 |
| Profit before tax | 2 | -1 | 0 | 0 | 0 | -3 | -0 | 3 | 11 | 8 | 14 | 33 | 30 |
| Tax % | 1% | 65% | 17% | 33% | -0% | -27% | 100% | 50% | 25% | 19% | 28% | 23% | |
| Net Profit | 2 | -2 | 0 | 0 | 0 | -2 | -0 | 1 | 8 | 7 | 10 | 26 | 23 |
| EPS in Rs | 1.55 | -2.25 | 0.06 | 0.03 | 0.01 | -2.30 | -0.10 | 1.47 | 8.44 | 6.65 | 10.05 | 25.88 | 22.76 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 700.00% | -12.50% | 42.86% | 160.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 600.00% | -712.50% | 55.36% | 117.14% |
Morgan Ventures Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 108% |
| 3 Years: | 40% |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 201% |
| 3 Years: | 43% |
| TTM: | 65% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 56% |
| 3 Years: | 18% |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 32% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: July 25, 2025, 1:01 pm
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 31 | 29 | 29 | 29 | 29 | 28 | 27 | 29 | 37 | 44 | 54 | 79 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 36 | 108 | 156 | 156 | 171 |
| Other Liabilities | 12 | 10 | 9 | 0 | 0 | 0 | 0 | 1 | 4 | 6 | 9 | 17 |
| Total Liabilities | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 278 |
| Fixed Assets | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 9 | 11 | 9 | 2 | 2 | 0 | 51 | 53 | 139 | 197 | 210 | 255 |
| Other Assets | 35 | 38 | 39 | 37 | 37 | 37 | 24 | 23 | 20 | 19 | 19 | 3 |
| Total Assets | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 278 |
Below is a detailed analysis of the balance sheet data for Morgan Ventures Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 25.00 Cr..
- For Borrowings, as of Mar 2025, the value is 171.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 156.00 Cr. (Mar 2024) to 171.00 Cr., marking an increase of 15.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2024) to 17.00 Cr., marking an increase of 8.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 278.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 229.00 Cr. (Mar 2024) to 278.00 Cr., marking an increase of 49.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 20.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 255.00 Cr.. The value appears strong and on an upward trend. It has increased from 210.00 Cr. (Mar 2024) to 255.00 Cr., marking an increase of 45.00 Cr..
- For Other Assets, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 16.00 Cr..
- For Total Assets, as of Mar 2025, the value is 278.00 Cr.. The value appears strong and on an upward trend. It has increased from 229.00 Cr. (Mar 2024) to 278.00 Cr., marking an increase of 49.00 Cr..
However, the Borrowings (171.00 Cr.) are higher than the Reserves (79.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 3.00 | -1.00 | 0.00 | 0.00 | 0.00 | -3.00 | -37.00 | -30.00 | -93.00 | -146.00 | -133.00 | -127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Inventory Days | -2,230 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 72 | 0 | 0 | -2,230 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Working Capital Days | 1,361 | 11,065 | 658,460 | 4,421 | 7,347 | 1,441 | 415 | 539 | 282 | -6 | ||
| ROCE % | 4% | -3% | 0% | 0% | 0% | -8% | 2% | 7% | 13% | 5% | 11% | 18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Jun 14 | Jun 13 | Jun 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
| Diluted EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
| Cash EPS (Rs.) | 0.06 | -2.12 | 2.56 | 1.08 | 2.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.54 | 4.18 | 4.13 | 4.00 |
| PBDIT / Share (Rs.) | 0.01 | -1.34 | 2.84 | 0.88 | 2.92 |
| PBIT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.19 | 1.83 |
| PBT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.58 | 1.17 |
| Net Profit / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
| NP After MI And SOA / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
| PBDIT Margin (%) | 0.00 | -246.91 | 68.05 | 21.43 | 73.09 |
| PBIT Margin (%) | 0.00 | -281.26 | 42.39 | -4.83 | 45.73 |
| PBT Margin (%) | 0.00 | -281.31 | 42.38 | -14.09 | 29.19 |
| Net Profit Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
| NP After MI And SOA Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
| Return on Networth / Equity (%) | 0.10 | -5.89 | 3.59 | 0.00 | 4.29 |
| Return on Capital Employeed (%) | 0.00 | -3.15 | 3.11 | -0.35 | 3.11 |
| Return On Assets (%) | 0.08 | -4.60 | 2.46 | 0.00 | 2.83 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.15 | 0.15 | 0.21 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.17 | 0.15 | 0.21 |
| Asset Turnover Ratio (%) | 0.00 | 0.01 | 0.07 | 0.07 | 0.07 |
| Current Ratio (X) | 2.49 | 13.52 | 5.19 | 8.13 | 11.95 |
| Quick Ratio (X) | 0.62 | 3.61 | 0.27 | 0.60 | 1.73 |
| Interest Coverage Ratio (X) | 67.43 | -4912.48 | 9984.77 | 2.31 | 4.42 |
| Interest Coverage Ratio (Post Tax) (X) | -11.85 | -8831.33 | 6145.96 | 0.38 | 3.59 |
| Enterprise Value (Cr.) | 7.47 | -1.79 | 14.72 | 11.69 | 11.19 |
| EV / Net Operating Revenue (X) | 0.00 | -3.32 | 3.56 | 2.86 | 2.81 |
| EV / EBITDA (X) | 404.43 | 1.35 | 5.23 | 13.33 | 3.84 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 8.13 | 1.88 | 1.50 | 0.73 |
| Price / BV (X) | 0.33 | 0.11 | 0.18 | 0.15 | 0.07 |
| Price / Net Operating Revenue (X) | 0.00 | 8.14 | 1.88 | 1.50 | 0.73 |
| EarningsYield | 0.00 | -0.52 | 0.19 | 0.00 | 0.58 |
After reviewing the key financial ratios for Morgan Ventures Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Diluted EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Cash EPS (Rs.), as of Mar 16, the value is 0.06. This value is below the healthy minimum of 3. It has increased from -2.12 (Mar 15) to 0.06, marking an increase of 2.18.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 0.00. It has decreased from 0.54 (Mar 15) to 0.00, marking a decrease of 0.54.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -1.34 (Mar 15) to 0.01, marking an increase of 1.35.
- For PBIT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For PBT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For PBDIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -246.91 (Mar 15) to 0.00, marking an increase of 246.91.
- For PBIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.26 (Mar 15) to 0.00, marking an increase of 281.26.
- For PBT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.31 (Mar 15) to 0.00, marking an increase of 281.31.
- For Net Profit Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 8. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.10. This value is below the healthy minimum of 15. It has increased from -5.89 (Mar 15) to 0.10, marking an increase of 5.99.
- For Return on Capital Employeed (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -3.15 (Mar 15) to 0.00, marking an increase of 3.15.
- For Return On Assets (%), as of Mar 16, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -4.60 (Mar 15) to 0.08, marking an increase of 4.68.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.00. It has decreased from 0.01 (Mar 15) to 0.00, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 2.49. This value is within the healthy range. It has decreased from 13.52 (Mar 15) to 2.49, marking a decrease of 11.03.
- For Quick Ratio (X), as of Mar 16, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 3.61 (Mar 15) to 0.62, marking a decrease of 2.99.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 67.43. This value is within the healthy range. It has increased from -4,912.48 (Mar 15) to 67.43, marking an increase of 4,979.91.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -11.85. This value is below the healthy minimum of 3. It has increased from -8,831.33 (Mar 15) to -11.85, marking an increase of 8,819.48.
- For Enterprise Value (Cr.), as of Mar 16, the value is 7.47. It has increased from -1.79 (Mar 15) to 7.47, marking an increase of 9.26.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -3.32 (Mar 15) to 0.00, marking an increase of 3.32.
- For EV / EBITDA (X), as of Mar 16, the value is 404.43. This value exceeds the healthy maximum of 15. It has increased from 1.35 (Mar 15) to 404.43, marking an increase of 403.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.13 (Mar 15) to 0.00, marking a decrease of 8.13.
- For Price / BV (X), as of Mar 16, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.11 (Mar 15) to 0.33, marking an increase of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.14 (Mar 15) to 0.00, marking a decrease of 8.14.
- For EarningsYield, as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.52 (Mar 15) to 0.00, marking an increase of 0.52.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morgan Ventures Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.1% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -11.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 3.09 (Industry average Stock P/E: 104.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 37, Ring Road, Lajpat Nagar - IV, New Delhi Delhi 110024 | morgan@morganventures.in http://www.morganventures.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kuldeep Kumar Dhar | Managing Director |
| Mr. Sanjiv Bansal | Independent Director |
| Mr. Yogesh Kumar Gupta | Independent Director |
| Mrs. Madhu | Woman Director |
FAQ
What is the intrinsic value of Morgan Ventures Ltd?
Morgan Ventures Ltd's intrinsic value (as of 24 October 2025) is 72.78 which is 3.38% higher the current market price of 70.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 69.7 Cr. market cap, FY2025-2026 high/low of 154/62.1, reserves of ₹79 Cr, and liabilities of 278 Cr.
What is the Market Cap of Morgan Ventures Ltd?
The Market Cap of Morgan Ventures Ltd is 69.7 Cr..
What is the current Stock Price of Morgan Ventures Ltd as on 24 October 2025?
The current stock price of Morgan Ventures Ltd as on 24 October 2025 is 70.4.
What is the High / Low of Morgan Ventures Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morgan Ventures Ltd stocks is 154/62.1.
What is the Stock P/E of Morgan Ventures Ltd?
The Stock P/E of Morgan Ventures Ltd is 3.09.
What is the Book Value of Morgan Ventures Ltd?
The Book Value of Morgan Ventures Ltd is 90.2.
What is the Dividend Yield of Morgan Ventures Ltd?
The Dividend Yield of Morgan Ventures Ltd is 0.00 %.
What is the ROCE of Morgan Ventures Ltd?
The ROCE of Morgan Ventures Ltd is 18.3 %.
What is the ROE of Morgan Ventures Ltd?
The ROE of Morgan Ventures Ltd is 32.0 %.
What is the Face Value of Morgan Ventures Ltd?
The Face Value of Morgan Ventures Ltd is 10.0.